Ovarian Squamous Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-05
Clinical Trial Update: Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of pembrolizumab for ovarian squamous cell carcinoma is currently active but not recruiting. The study is sponsored by Niigata…